Risk factors and drug discovery for cognitive impairment in type 2 diabetes mellitus using artificial intelligence interpretation and graph neural networks.

Zhang, Xin; Xie, Jiajia; You, Xiong; Gong, Houwu

Zhang, Xin; Xie, Jiajia; You, Xiong; Gong, Houwu.

Affiliation

Zhang X; Department of Pediatric, The First Affiliated Hospital of Hunan College of Traditional Chinese Medicine, Zhuzhou, China.
Xie J; Department of Ultrasound Imaging, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
You X; Center of Rehabilitation diagnosis and Treatment, Hunan Provincial Rehabilitation Hospital, Changsha, China.
Gong H; College of Computer Science and Electronic Engineering, Hunan University, Changsha, China.

Front Endocrinol (Lausanne) ; 14: 1213711, 2023.

Article in En | MEDLINE | ID: mdl-37693358

Subject(s)

Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Artificial Intelligence; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Neural Networks, Computer; Risk Factors; Cognitive Dysfunction/epidemiology; Cognitive Dysfunction/etiology; Drug Discovery

Key words

cognitive impairment; drug discovery; graph neural network (GNN); risk factors; type 2 diabetes mellitus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Cognitive Dysfunction Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google